Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Top Montana Infectious Disease Doctor Publishes Coronavirus Book; Dr. David Graham's 'From Killer to Common Cold' Walks Readers Through Basics of What's Next for Covid-19

Billings Doctor's Book Details Theory of Covid-19's Five Year Plan as it Transitions From a Pandemic to a Common Cold Virus


News provided by

Dr. David Graham

Oct 14, 2020, 04:00 ET

Share this article

Share toX

Share this article

Share toX

Author and Infectious Disease Doctor David Graham publishes book: 'From Killer to Common Cold'
Author and Infectious Disease Doctor David Graham publishes book: 'From Killer to Common Cold'
Youtube
Youtube

BILLINGS, Mont., Oct. 14, 2020 /PRNewswire-PRWeb/ -- "Too often, people don't tell you what to expect from Covid-19. What is next? Where do we go from here? What if we start by understanding what a virus wants and finish by understanding the end-game of Covid-19: it will become another common cold coronavirus," says Author and Infectious Disease Doctor David Graham. "I predict it will be two to five years before the transitional phase ends and Covid-19 is merely a cause of the common cold."

Dr. David Graham is a practicing board certified infectious diseases physician in Billings, Montana. He's also a Covid-19 business consultant and expert witness, a retirement planner for physicians, a financial and medical blogger at FiPhysician, a published author, a husband and a father of three young kids. His book, From Killer to Common Cold: Herd Protection and the Transitional Phase of Covid-19 launched worldwide October, 2020 and is available in paperback and eBook versions via Amazon Prime. The eBook version is also available via Barnes & Noble for Nook and Kobo.

Too often, people don’t tell you what to expect from Covid-19. What is next? Where do we go from here? What if we start by understanding what a virus wants and finish by understanding the end-game of Covid-19: it will become another common cold coronavirus.

Post this

Throughout the short, 111-page book, Dr. Graham outlines his theory on the destiny of SARS-CoV-2 in an easy-to-understand way.

"I believe that the destiny of SARS-CoV-2 is already written. With or without a vaccine, with or without an effective treatment, with or without expected technological advances, we are destined to interact with this virus forever. SARS-CoV-2 is not eradicable and will become endemic," says Dr. Graham. "There are already four coronaviruses that are endemic and cause the common cold. SARS-CoV-2 will become the fifth endemic human coronavirus. The virus that causes COVID-19 will become another common cold."

The book also discusses herd immunity vs. herd protection and allows the reader to understand the many factors in their community that affect the timeline of the virus reaching its end-game and transitioning into a common cold.

"This virus has changed the world. It's made it difficult to visualize our life and our travel plans over the next several years," says stay at home mom + lifestyle TV host Dianne Parker. "Dr. Graham's book has given us a different view to consider. It has helped our family put everything into perspective. As a huge bonus, I get to be the smart mom who teaches my kids a lesson about how viruses work."

"From Killer to Common Cold is a wonderful read. It is honest and refreshing. It answers a lot of my questions. I've found that health experts have been afraid at times to deliver the honest goods on the virus, vaccines and the pandemic in general. Dr. Graham's book also gives us hope that we can and will get 'to the other side'," says Dale Roberts, an advocate for low fee index investing.

"The question on everyone's mind right now is how and when does this end? As for when, Dr. Graham suggests it will be two to five years before things return to a pre-pandemic level of activity. But even then perhaps life will seem very different and foreign to us today, (but) when it comes to humanity versus the virus, Dr. Graham suggests we lay our money down on humanity overcoming this new obstacle and flourishing again," says Anesthesiologist and host of The Paradocs Podcast Dr. Eric Larson.

"Dr. Graham's infectious disease expertise paired with his ability to explain complex medical information to the average reader shines in this book. It's a phenomenal read and I highly recommend this," says Billings, Montana Physician Dr. Tom James.

More information and excerpts from the book are available at http://www.fiphysician.com. Visual content, including downloadable videos, photos and graphics, are available here.

SOURCE Dr. David Graham

Related Links

http://www.fiphysician.com/

Modal title

Dr. David Graham unboxes book order
Dr. David Graham unboxes book order
Book order unboxing - From Killer to Common Cold
Book order unboxing - From Killer to Common Cold
Dr. David Graham
Dr. David Graham
Dr. David Graham unboxes book order Book order unboxing - From Killer to Common Cold Dr. David Graham

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.